Forest Sues Torrent, Watson, Glenmark Over Bystolic Generic

Forest Laboratories Inc. sued Torrent Pharmaceuticals Ltd., Watson Pharmaceuticals Inc., Glenmark Pharmaceuticals Ltd. and two other drugmakers claiming they seek to sell a generic version of the hypertension pill Bystolic before a U.S. patent expires.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.